Form 4 for AGL agilon health, inc.
Accepted 2026-06-04 21:56:15 ET · period of report 2026-06-02 · accession 0001628280-26-041022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-04 21:56 | 2026-06-02 | AGL | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +2,133 | 7,633 | +39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-02 | A | A | 2,133 | $0.00 | 7,633 | D | — | — | (F1) Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director. (F2) The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. (F3) Includes restricted stock units. |